NuVasive
Develops 3D-printed porous titanium spinal implants (Modulus) using additive manufacturing for minimally invasive spine surgery.
- CEO / Founder
- J. Christopher Barry
- Team Size
- 1001-5000
- Stage
- Acquired
- Total Funding
- $55M
- Latest Round
- Acquired
- Key Investors
- Kleiner Perkins; JPMorgan Partners
Technology & Products
Key Products
Modulus XLIF; Modulus ALIF; Precice limb lengthening system; Surgical planning software; Neuromonitoring systems
Technological Advantage
Uses 3D printing to create complex porous structures that enhance bone ingrowth, protected by patents (though not specified).
Differentiation
Value Proposition
Reduces surgery time and improves fusion rates with 3D-printed porous titanium implants that mimic bone structure.
How They Differentiate
Focus on minimally invasive lateral spine surgery with integrated procedural solutions; 3D-printed implants with advanced porous architecture.
Market & Competition
Target Customers
Hospitals, surgeons, healthcare providers
Industry Verticals
Medical; Spine surgery
Competitors
Medtronic; Stryker; Globus Medical
Growth & Milestones
Growth Metrics
Revenue ~$1.1B in 2021; ~2,700 employees
Major Milestones
IPO in 2004; Launched Modulus 3D-printed titanium implants in 2017; Acquired by Globus Medical in 2023
Notable Customers
Hospital for Special Surgery; Mayo Clinic; Cleveland Clinic; Johns Hopkins Hospital; UCLA Health